Development of an item bank for computerized adaptive test (CAT) measurement of pain by Petersen, MA et al.
European Journal of Pain
 
Development of an item bank for computerized adaptive test (CAT) measurement of
pain
--Manuscript Draft--
 
Manuscript Number:
Article Type: Original Manuscript
Corresponding Author: Morten Aagaard Petersen
Copenhagen, DENMARK
First Author: Morten Aagaard Petersen
Order of Authors: Morten Aagaard Petersen
Neil K. Aaronson
Wei-Chu Chie
Thierry Conroy
Anna Costantini
Eva Hammerlid
Marianne J. Hjermstad
Stein Kaasa
Jon H. Loge
Galina Velikova
Teresa Young
Mogens Groenvold
Abstract: Background: Patient-reported outcomes should ideally be adapted to the individual
patient while maintaining comparability of scores across patients. This is achievable
using computerized adaptive testing (CAT). The aim here was to develop an item bank
for CAT measurement of the pain domain as measured by the EORTC QLQ-C30
questionnaire.
Methods: The development process consisted of four steps. 1) Literature search. 2)
Formulation of new items. 3) Pre-testing. 4) Field-testing and psychometric analyses
for the final selection of items.
Results: In step 1) we identified 337 pain items from the literature. 2) Twenty-nine new
items fitting the QLQ-C30 item style were formulated. Expert evaluations reduced this
to 26 items. 3) Based on patient interviews (N=31) the list was further reduced to 21
items. 4) We obtained responses from 1,103 cancer patients from five countries.
Psychometric evaluations showed that 16 items could be retained in a unidimensional
item bank. Evaluations indicated that use of the CAT measure may reduce sample size
requirements with 15-25% compared to using the QLQ-C30 pain scale.
Conclusions: We have established an item bank of 16 items suitable for CAT
measurement of pain. We recommend initiating CAT measurement by screening for
pain using the two original QLQ-C30 pain items.
Suggested Reviewers: Dennis Revicki
Dennis.Revicki@unitedbiosource.com
Mathias Rose
rose@charite.de
Bryce Reeve
reeveb@mail.nih.gov
Dagmar Amtmann
dagmara@u.washington.edu
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
  
 
 1 
 2014-01-31 
 
 
 
 
 
 
 
 
e-mail  
 
 
 
Dept. of Palliative Medicine 
 
+45 3531 2025 
+45 3531 2071 
Mpet0009@bbh.regionh.dk  
 
European Journal of Pain 
 
 
Submission of article manuscript 
 
We would like to submit an original article manuscript for possible publication in the European 
Journal of Pain. The manuscript has not been published or submitted for publication elsewhere. 
 
Manuscript title: 
Development of an item bank for computerized adaptive test (CAT) measurement of pain   
 
Short summary of the study: 
An item bank of 16 items allowing for CAT measurement of pain was developed. This is ex-
pected to clearly improve EORTC measurement of pain. 
 
Author contributions:  
Morten Aa. Petersen: conception and design; analysis and interpretation of data; drafting the 
article; final approval of the version to be published. 
Neil K. Aaronson: conception and design; interpretation of data; revising the article critically 
for important intellectual content; final approval of the version to be published. 
Wei-Chu Chie: acquisition of data; revising the article critically for important intellectual con-
tent; final approval of the version to be published. 
Thierry Conroy: acquisition of data; revising the article critically for important intellectual con-
tent; final approval of the version to be published.  
Anna Costantini: acquisition of data; revising the article critically for important intellectual 
content; final approval of the version to be published.  
Eva Hammerlid: acquisition of data; revising the article critically for important intellectual 
content; final approval of the version to be published. 
Cover Letter
  
 
 2 
Marianne J. Hjermstad: Acquisition of data (literature review); revising the article critically 
for important intellectual content; final approval of the version to be published. 
Stein Kaasa: Acquisition of data (literature review); revising the article critically for important 
intellectual content; final approval of the version to be published. 
Jon H. Loge: Acquisition of data (literature review); revising the article critically for important 
intellectual content; final approval of the version to be published. 
Galina Velikova: conception and design; acquisition of data; revising the article critically for 
important intellectual content; final approval of the version to be published. 
Teresa Young: acquisition of data; revising the article critically for important intellectual con-
tent; final approval of the version to be published.  
Mogens Groenvold: conception and design; interpretation of data; revising the article critically 
for important intellectual content; final approval of the version to be published. 
 
 
As possible reviewers for this manuscript we suggest: 
 Dennis A. Revicki: Center for Health Outcomes Research, United BioSource Corporation, 
7101 Wisconsin Ave., Suite 600, Bethesda, MD 20814, USA. Den-
nis.Revicki@unitedbiosource.com  
 Mathias Rose: Psychosomatische Medizin und Psychotherapie, Charité-Universitätsmedizin 
Berlin, Berlin, Germany. rose@charite.de  
 Bryce B. Reeve: Outcomes Research Branch, Applied Research Program, Division of Cancer 
Control and Population Sciences, National Cancer Institute, EPN 4088, 6130 Executive 
Blvd., MSC 7344, Bethesda, MD 20892-7344, USA. reeveb@mail.nih.gov 
 Dagmar Amtmann, Ph.D., Research Assistant Professor, University of Washington, Depart-
ment of Rehabilitation Medicine, Box 357920, Seattle, WA 98195-7920, (206) 543-4741 V, 
(206) 685-9224 FAX, dagmara@u.washington.edu  
 
 
Conflict of Interest Statement 
The study was funded by a grant from the EORTC Quality of Life Group. There were no finan-
cial relationships, personal relationships, academic competition, intellectual commitments, or 
other conflicts of interest that might have biased the work. 
 
 
  
 
 3 
 
Yours sincerely on behalf of the authors, 
 
Morten Aa. Petersen 
The Research Unit, Department of Palliative Medicine,  
Bispebjerg Hospital,  
Bispebjerg bakke 23,  
2400 Copenhagen NV, Denmark.  
Telephone: (+45) 3531 2025. Fax: (+45) 3531 2071. Email: mpet0009@bbh.regionh.dk 
Background: Patient-reported outcomes should ideally be adapted to the individual patient while 
maintaining comparability of scores across patients. This is achievable using computerized adaptive 
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as measured by the EORTC QLQ-C30 questionnaire.  
Methods: The development process consisted of four steps. 1) Literature search. 2) Formulation of 
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Results: In step 1) we identified 337 pain items from the literature. 2) Twenty-nine new items 
fitting the QLQ-C30 item style were formulated. Expert evaluations reduced this to 26 items. 3) 
Based on patient interviews (N=31) the list was further reduced to 21 items. 4) We obtained 
responses from 1,103 cancer patients from five countries. Psychometric evaluations showed that 16 
items could be retained in a unidimensional item bank. Evaluations indicated that use of the CAT 
measure may reduce sample size requirements with 15-25% compared to using the QLQ-C30 pain 
scale.  
Conclusions: We have established an item bank of 16 items suitable for CAT measurement of pain. 
We recommend initiating CAT measurement by screening for pain using the two original QLQ-C30 
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What's already known about this topic? 
 The EORTC QLQ-C30 is a well-validated and widely used questionnaire for 
measuring health-related quality of life including pain. 
 Computer adaptive testing (CAT) adapts the questionnaire to the individual, thereby 
optimising measurement efficiency and reliability. 
 
What does this study add? 
 An item bank of 16 items for CAT measurement of pain was developed. 
 The new items measure the same pain aspects as the QLQ-C30 pain scale. 
 The new EORTC CAT instrument improves the measurement of pain compared to the 
QLQ-C30. 
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Abstract:  
Background: Patient-reported outcomes should ideally be adapted to the individual patient 
while maintaining comparability of scores across patients. This is achievable using 
computerized adaptive testing (CAT). The aim here was to develop an item bank for CAT 
measurement of the pain domain as measured by the EORTC QLQ-C30 questionnaire.  
Methods: The development process consisted of four steps. 1) Literature search. 2) 
Formulation of new items. 3) Pre-testing. 4) Field-testing and psychometric analyses for the 
final selection of items.  
Results: In step 1) we identified 337 pain items from the literature. 2) Twenty-nine new items 
fitting the QLQ-C30 item style were formulated. Expert evaluations reduced this to 26 items. 
3) Based on patient interviews (N=31) the list was further reduced to 21 items. 4) We 
obtained responses from 1,103 cancer patients from five countries. Psychometric evaluations 
showed that 16 items could be retained in a unidimensional item bank. Evaluations indicated 
that use of the CAT measure may reduce sample size requirements with 15-25% compared to 
using the QLQ-C30 pain scale.  
Conclusions: We have established an item bank of 16 items suitable for CAT measurement 
of pain. We recommend initiating CAT measurement by screening for pain using the two 
original QLQ-C30 pain items.  
 
Key words: Computerized adaptive test; EORTC QLQ-C30; item response theory; item 
development; item banking; pain assessment; patient-reported outcome. 
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Introduction 
Adequate pain management requires reliable and precise assessment. As pain is a subjective 
symptom, assessment should be based on the patients’ own perception of their pain (Green et 
al., 2010; Noble et al., 2005). This can be achieved using self-report questionnaires, also 
termed patient-reported outcomes (PROs). PROs have typically been developed using 
classical methods like sum scoring of items. However, classical methods have some 
limitations. For example, all patients have to answer the same set of items for scores to be 
comparable. This means that patients often have to answer items that are not relevant for their 
level of pain and/or relevant items are missing since the total number of items has to be 
limited to keep the respondent burden at a reasonable level.  
 
Using item response theory (IRT) (Hambleton et al., 1991; van der Linden and Hambleton, 
1997) for developing and scoring PROs overcomes some of these limitations. In particular, 
when a set of items has been calibrated (estimated) to an IRT model all scores based on any 
subset of the items are comparable. This unique feature means that a questionnaire can be 
adapted to the individual without compromising comparability across patients. This is utilized 
in computer adaptive testing (CAT): (Wainer, 2000) based on the responses to the preceding 
items, a computer program evaluates which item should be asked next to obtain maximal 
information. In this way the questionnaire is adapted to the individual, using the most 
informative items for each patient, thereby optimising both the efficiency and the reliability of 
the assessment.  
 
The European Organisation for Research and Treatment of Cancer Quality of Life Group 
(EORTC QLG) (http://groups.eortc.be/qol/) is carrying out a large scale project with the 
overall aim to improve the measurement of the health-related quality of life (HRQOL) 
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domains included in the EORTC Quality of Life Questionnaire, the QLQ-C30 (Aaronson et 
al., 1993; Giesinger et al., 2011; Petersen et al., 2012; Petersen et al., 2013; Petersen and 
Groenvold, 2013; Petersen et al., 2010; Petersen et al., 2011). This is achieved by developing 
a CAT measure for each domain in the EORTC QLQ-C30. This CAT instrument will be more 
precise, efficient, and flexible than the EORTC QLQ-C30.  
 
The QLQ-C30 is one of the most widely used HRQOL questionnaires in cancer research 
(Fayers and Bottomley, 2002; Garratt et al., 2002). It consists of 30 items measuring 15 
aspects of HRQOL. In the QLQ-C30 pain is measured with two items, one about pain 
intensity (“Have you had pain?”) and one about pain interference (“Did pain interfere with 
your daily activities?”) combined into a single overall score (Fayers et al., 2001). These are 
generic items relevant for all patients. However, if more items assessing different levels of 
pain intensity/interference were available, more precise pain measurement could be obtained. 
With CAT this can be achieved without imposing an unreasonable response burden on the 
patients. 
 
The aim of the study was to develop a collection of items (a so-called “item bank”) for CAT 
measurement of the pain domain as measured with the QLQ-C30. The intention is to 
supplement the two pain-items of the QLQ-C30 with new items thereby increasing 
measurement precision and extend the range of pain intensity/interference that can be 
assessed. The current paper describes the development and initial validation of this EORTC 
pain item bank. 
 
Materials and Methods 
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The general steps in the development of the item banks for the CAT version of the EORTC 
QLQ-C30 have been described in detail previously (Giesinger et al., 2011; Petersen et al., 
2012; Petersen et al., 2013; Petersen et al., 2010; Petersen et al., 2011). The following 
summarises each step of the development of the pain item bank.  
 
1. Literature search 
A literature search was conducted to identify existing instruments and items used to measure 
pain. This was not a systematic review, but rather aimed at acquiring sufficient information 
about pain measurement to form the basis for formulating new, relevant items. In the current 
case, the literature search was primarily based on an early version of the review of pain 
assessment tools conducted by the European Palliative Care Research Collaborative (Holen et 
al., 2006). This list of items was supplemented with searches for additional pain items in the 
PROQOLID database (http://www.proqolid.org) and the EORTC QLG Item Bank. 
 
2. Formulation of items and expert evaluations 
First, the list of items identified in step 1 was trimmed: items assessing aspects of pain other 
than intensity or interference and items with content that did not fit the “QLQ-C30 item style” 
(i.e., the response categories, time frame, etc.) were deleted. The resulting “shortlist” of items 
was used as inspiration for formulating new items measuring pain intensity and interference. 
The new items should have the same item style as the two QLQ-C30 pain items, i.e. they 
should fit the timeframe “during the past week” and the response options “not at all”, “a 
little”, “quite a bit” and “very much”. The intension was that the new items should extend the 
range of pain that could be assessed (from minimal to very high levels of pain). Therefore, we 
aimed at formulating items relevant for different levels of pain. The item selection and 
formulation was carried out independently by two members of the project group. After each 
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step, possible differences were discussed and a consensus was reached. The list of developed 
items was evaluated by international experts in pain measurement. The item list was revised 
based on these experts’ evaluations. 
 
3. Pre-testing 
The revised list of items was evaluated by a mixed, international sample of cancer patients. 
Before the interviews, the items were translated into the relevant languages by the Translation 
Office of the EORTC Quality of Life Department according to rigorous and well-established 
guidelines developed by the EORTC (Dewolf et al., 2009; Koller et al., 2007). The interviews 
followed the EORTC QLG guidelines for pre-testing of items (Johnson et al., 2011) and 
elucidated whether patients found some of the items difficult to answer, confusing, annoying, 
upsetting, intrusive, etc.  
 
4. Field-testing and psychometric analyses 
The items were field-tested in an international and heterogeneous sample of cancer patients. 
The sample included patients having different levels of pain, from “no” pain to “severe” pain.  
To ensure stable calibration of the IRT model, we aimed to collect at least 1,000 responses 
(Muraki and Bock, 1996). The patients completed the new pain items together with the QLQ-
C30.  They also completed sociodemographic items and “debriefing items” to clarify whether 
certain items were inappropriate, ambiguous, etc.  
 
The resulting dataset formed the basis for the final psychometric evaluations. These 
evaluations included:  
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a. Descriptive and basic statistical analyses. This included calculation of item mean scores, 
response frequencies, percent missing responses, and correlations with the QLQ-C30 pain 
scale. 
b. Evaluation of dimensionality and local dependence. As the QLQ-C30 assesses pain using 
a unidimensional scale, the aim was a unidimensional CAT measure of pain. We used 
factor analysis for ordinal variables to explore the dimensionality of the item set (Muthen, 
1984; Muthen and Muthen, 2002). This included evaluations of dimensionality based on 
eigenvalues (including scree plot (Cattell, 1966)) and the following fit indices: root mean 
square error of approximation (RMSEA), the Tucker-Lewis Index (TLI) and the 
Comparative Fit Index (CFI). Local independence (i.e. whether item responses are 
independent when controlling for the overall level of pain (van der Linden and 
Hambleton, 1997)) was investigated using residual correlations (Bjorner et al., 2003; 
Fliege et al., 2005; van der Linden and Hambleton, 1997).   
c. Calibration of the IRT model and evaluation of item fit. We used the generalized partial 
credit model (GPCM) (Muraki, 1997) as the IRT model forming the basis for the CAT. 
This was calibrated using Parscale (Muraki and Bock, 1996). In the GPCM, each item has 
a slope parameter describing the item’s ability to discriminate between subjects with 
different levels of pain, and a set of threshold parameters describing how likely it is to 
report problems on the item. Item fit was examined using Muraki’s test (Muraki, 1997), 
bias estimates (average difference between expected and observed item responses) and 
the infit and outfit statistics, which are mean square residuals often used in Rasch fit 
analysis (Bond and Fox, 2007; Petersen et al., 2013; Wright and Linacre, 1994; Wright 
and Masters, 1982). Infit and outfit values between 0.7 and 1.3 are often regarded as 
acceptable (Wright and Linacre, 1994). 
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d. Test for differential item functioning (DIF). DIF analysis explores whether items function 
differently for different groups of patients (Holland and Wainer, 1993). Using ordinal 
logistic regression methods (French and Miller, 1996; Petersen et al., 2003) we tested for 
DIF with regard to gender, age, country, cancer site, cancer stage, current treatment, 
education, work, and cohabitation. Significant DIF findings (Bjorner et al., 1998; 
Petersen et al., 2003) were evaluated for their impact on the estimation of pain, i.e. 
whether the DIF findings seemed to have practical consequences for pain estimation 
(Hart et al., 2009; Petersen et al., 2013; Petersen et al., 2011). 
e. Evaluation of measurement properties. We evaluated the measurement precision of the 
resulting CAT pain measure using simulations of CAT administration based on the 
collected responses. We simulated CATs asking 1, 2,… up to all but 1 item, respectively, 
estimated the pain score based on these CATs, and compared them with the pain score 
based on all items. Using two-sample t-test sizes we evaluated the relative validity (RV) 
of these CATs as compared to the QLQ-C30 pain scale in detecting expected group 
differences (Fayers and Machin, 2007). We hypothesized that patients currently on 
treatment (chemotherapy or other cancer related treatment) would have significantly 
more pain than patients not on treatment, and that patients with stage III or IV disease 
would have more pain than patients with stage I or II disease. In addition to these 
evaluations based on the observed data, we also evaluated the RV of the CATs based on 
simulated data. We simulated responses to the items based on pain scores sampled from 
normal distributions with different means. We compared groups of size N1=N2=25, 50, 
and 100, respectively and true effect sizes (ESs) of 0.2, 0.5, and 0.8, respectively. For 
each of these 3x3=9 possible settings, we ran 2,000 simulations. For further details please 
see Petersen el al. (Petersen et al., 2012) From the RVs we estimated the approximate 
savings in sample sizes using the CATs compared to the QLQ-C30 scale. The RVs can 
 11 
also be expressed as ratios of SDs, e.g. a RV=1.1 corresponds to a ratio of SDs of 1.1
-1
 = 
0.9 (when the mean difference is fixed) reflecting that a more precise measure results in 
less noise (smaller SD).  From these ratios of SDs approximate sample size reductions 
can be estimated (Petersen et al., 2012). 
 
The study was approved by the local ethical committees in the participating countries. 
Informed consent was obtained from each participating patient. 
 
Results 
1. Literature search 
The review of pain assessment tools (Holen et al., 2006) resulted in a list of 231 items. This 
was supplemented with 65 additional pain items identified in PROQOLID and with 41 items 
identified in the EORTC QLG Item Bank, resulting in a total of 337 pain items.  
 
2. Formulation of items and expert evaluations 
We classified the identified items as measuring either pain intensity, interference or 
something else. Only items judged to measure pain intensity or interference were retained.  
As the two QLQ-C30 items ask about pain, in general, without reference to specific body 
parts, the items were further required to ask about pain in general or to be able to be 
reformulated to do so. In all, 140 items complied with these requirements and were therefore 
retained. Next, we deleted redundant items and items that could not be reformulated into the 
QLQ-C30 item style. This resulted in the deletion of 113 items, leaving a list of 27 items. For 
example, “How OFTEN did you have it (pain)?” did not fit the response categories in the 
QLQ-C30 and “Over the past 3 days, have you been affected by pain?” was judged to be too 
close in content to the QLQ-C30 item “Have you had pain?”. The remaining 27 items were 
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used as inspiration for formulating new, unique items complying with the QLQ-C30 item 
style. This resulted in the formulation of 29 new candidate pain items.   
 
The 29 items were evaluated by 11 experts from Denmark, Germany, Italy, the Netherlands, 
and the UK. The expert evaluations resulted in rewording of three items and deletion of four 
items: two because of redundancy, one because of ambiguity and one because of poor fit to 
the response options. The expert evaluations resulted in the addition of one new item. Hence, 
after these evaluations, the list consisted of 26 items.  
 
3. Pre-testing 
A total of 31 patients were interviewed about the 26 candidate items and the two QLQ-C30 
pain items. The patients came from Denmark, France and the UK and included both genders 
and 11 different cancer sites. Based on the interviews we changed the wording of four items 
to make them clearer and seven items were deleted: five because of redundancy and two 
because several patients found them ambiguous/unclear. Hence, after these interviews the list 
consisted of 19 candidate items plus the two QLQ-C30 items, in all 21 pain items. Of these, 
15 measured pain interference and six pain intensity. 
 
4. Field-testing and psychometric analyses 
We obtained responses from 1,103 cancer patients. Patient characteristics are reported in 
Table 1.  
a. Descriptive and basic statistical analyses. The response rate per item was generally high 
(98.1%-99.1%). The average response across the items ranged from 0.33 to 0.86 on a 0-3 
scale (with 0=”not at all”), indicating generally low pain levels in the sample, although about 
250 patients (23%) reported “quite a bit” or “very much” pain (item 21). Polychoric 
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correlations between the new items and the QLQ-C30 pain scale ranged from 0.79 to 0.92.  
 
(Table 1 about here) 
 
b. Evaluation of dimensionality and local dependence. Exploratory eigenvalues analysis 
indicated that the first factor explained 85% of the total variation. Subsequent factors all 
explained <4% of the variation and all had eigenvalues<1. A unidimensional solution with the 
21 items had RMSEA=0.147, CFI=0.977, TLI=0.995. The RMSEA was somewhat large, but 
all other indices indicated that all 21 items could be retained in a unidimensional model. All 
residual correlations between the 21 items were <0.10, i.e. no indications of local dependence. 
Therefore, all 21 items were retained. 
 
c. Calibration of the IRT model and evaluation of item fit. Our initial attempts to fit an IRT 
model to the 21 items failed; either the estimation procedure could not converge or it resulted 
in unreliable, extreme estimates of some parameters. Inspections of item crosstabs and 
correlations revealed that, although residual correlations did not indicate local dependence, 
several items were highly correlated (polychoric correlations>0.9). The main reason was that 
38% of the sample had responded “not at all” (i.e. no pain) to all items. The responses from 
these patients are clearly mutually highly predictable/locally dependent. Among patients 
responding “not at all” to the two original QLQ-C30 pain items (44% of the sample), 85% 
had responded “not at all” to all items, and their average score was 0.7 on a 0-100 scored sum 
scale consisting of the 21 items. Hence, asking these “no pain” patients several pain items 
would have very little relevance from either a clinical or a measurement perspective. 
Therefore, we decided to exclude the patients responding “not at all” to the two QLQ-C30 
pain items from the IRT analyses. Doing this, it was possible to fit an IRT model. Evaluation 
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of item fit indicated that five items had poor fit to the model and/or were locally dependent 
with some of the other items and were therefore deleted. Fit statistics for the remaining 16 
items are shown in Table 2. All item fit tests had p>0.04 (and except for item 11 all >0.10). 
Bias estimates were all very close to 0 (<0.1). The infit statistics ranged 0.76-1.07 and the 
outfit statistics 0.71-1.03; all within the acceptable range. Hence, the fit of these 16 items was 
deemed acceptable. 
 
(Table 2 about here) 
 
d. Test for DIF. There was no significant DIF with regard to age, gender, cancer stage, 
education, or cohabitation. Items 4, 6, 7, and 21 showed significant DIF between countries 
and item 7 also showed DIF between patients on and off treatment. There was significant DIF 
between cancer sites for item 16 and between working and retired patients for item 18. We 
evaluated the possible impact of these DIF findings for the estimation of pain. These 
evaluations indicated that the possible DIF would have only negligible impact on the 
estimation of pain, i.e. the possible DIF did not result in biased pain scores for any groups of 
patients. Therefore, no items were deleted because of DIF. 
 
Parameter estimates of the final 16 items are shown in Table 2. The slopes indicate how well 
the items discriminate between different levels of pain, while the locations (the average of the 
item’s threshold parameters) indicate the level of pain for which the items are most 
informative. Except for item 21 all locations were >0 indicating that the items were mainly 
relevant for patients with at least a little pain. This is also evident from Fig. 1 which shows the 
total information when using all 16 items and the two QLQ-C30 items only, respectively. 
Considering information=10 (corresponding to a reliability of 0.90) as a threshold for reliable 
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measurement, the total item bank provided reliable measurement from about –1.0 to 2.5 (3.5 
standard deviation units). Asking the two QLQ-C30 items only provide markedly less 
information for all levels of pain except for patients with “no pain” (lower extreme). Hence, 
the two QLQ-C30 items may be particularly useful for screening for patients with “no pain”; 
88% of those answering “not at all” to these two items, answer “not at all” (i.e. “no pain”) to 
all 16 items. 
 
(Fig. 1 about here) 
(Fig. 2 about here) 
 
e. Evaluation of measurement properties.  
Fig. 2 shows that for CATs of all lengths the median pain score was very close to the median 
score based on all items (all deviations<0.06). For about 50% of the patients the scores 
obtained using only one item deviated >0.4 from the score based on all items, while when 
asking five items only about 10% had scores deviating >0.4. As the score based on all items 
ranged from -2.2 to 3.0, 0.4 is less than 8% of the possible score range, i.e. similar to 8 points 
on a 0-100 scale. Scores based on one item correlated 0.77 with the scores based on all items, 
with two items the correlation was 0.88, while using three or more items the correlations were 
>0.92 (results not shown).  
 
Fig. 3 summarizes the results of the known-groups comparisons. The comparisons based on 
the observed data confirmed the hypothesized group differences and indicated that CAT 
measurement asking four or more items reduced the sample size requirements by about 20-
25% without loss of power compared to using the original QLQ-C30 pain scale. The 
estimated reduction in required sample size/increased power was somewhat lower based on 
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the simulated data. These simulations indicated that, regardless of the length of the CAT, 
sample sizes may be reduced by less than 15%, and at least seven items may be required for a 
reduction >10%. 
 
(Fig. 3 about here) 
 
Discussion and conclusions 
The EORTC QLG is developing a CAT instrument for assessing the HRQOL domains 
included in the widely used EORTC QLQ-C30 questionnaire. The EORTC CAT development 
process can be divided into four phases: literature search, item construction, pre-testing, and 
field-testing. These phases are closely related to the phases of EORTC QLG module 
development (Johnson et al., 2011). Here we have reported the results of the development of 
the pain item bank.  
 
The literature search yielded valuable insights into how pain may be measured. This was a 
useful inspiration for formulating items measuring pain in the “EORTC QLQ-C30 way”.  
Note that the literature search was not, and was not intended to be, an exhaustive review of all 
available pain items, but was intended to identify the different ways pain items may be 
formulated to cover different aspects and levels of pain. With the identification of over 300 
pain items we feel confident that all relevant item variants were covered sufficiently. From the 
literature search and item formulation it was apparent that, with our requirements for item 
formatting (response options etc.), it was difficult to construct a large number of relevant and 
distinct items, particularly about pain intensity. Hence, only four of the 16 items in the final 
item bank ask directly about pain intensity. The remaining items measure pain interference. 
But clearly, these items also provide valuable insight into the level of pain (the more pain 
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interfered, the more severe it was likely to have been). The psychometric analysis also 
indicated that the intensity and interference items together formed a unidimensional construct. 
Still, it may be preferable to avoid asking only interference items. In this case the CAT can be 
programmed to always include both intensity and interference items. 
  
Basing the CAT on an established HRQOL instrument, the QLQ-C30, has several advantages 
including backward compatibility with a very large literature, measurement of well-validated 
HRQOL domains, and simplified conceptual work as we did not have to establish a whole 
new framework of measurement. However, this approach limited the number of relevant 
items that could be constructed. Still, we have extended the QLQ-C30 pain scale from two to 
16 items, a considerable expansion. 
 
The expert and patient evaluations were invaluable in identifying problematic items, and in 
optimizing item formulation. The patient perspective was particularly important in ensuring 
that the items are appropriate and comprehensible for cancer patients. We deleted seven of the 
candidate items because of redundancy or other problems pointed out by patients during the 
pre-testing. 
 
The psychometric analyses indicated that 16 items could be retained in a unidimensional item 
bank. IRT calibration and evaluations generally showed good fit of these items. We found 
some indications of DIF. However, evaluations of the DIF indicated that these had no 
significant impact on the estimation of pain. Hence, we consider the items to be appropriate 
for general use in cancer patients, regardless of gender, age, cancer site etc. Further, as the 
items have been developed, calibrated and evaluated in an international setting, the CAT 
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measure will be appropriate for international use. As with the QLQ-C30, the CAT measure is 
intended to be applicable and available in a multitude of languages. 
 
To estimate the IRT model we had to exclude a substantial proportion of patients (44% of our 
sample) who had responded “not at all” to the two QLQ-C30 pain items. The responses from 
these patients reflected that they generally had no or very little pain and, hence, detailed 
questioning about their level of pain would have little relevance from either a clinical or a 
measurement perspective. Further, as is apparent from the item location parameters which all 
are > 0 except for item 21 (Table 2) and the information function (Fig. 1), the items are 
primarily relevant for patients who have at least a little pain. Therefore, it may be most 
appropriate to first screen patients for pain using the two QLQ-C30 pain items. Only those 
patients who report at least “a little” pain on one of these two items would then go on to 
complete the CAT items (the number of which would depend on the desired level of 
measurement precision).  
 
In general, the CAT pain items appeared to be efficient and precise. For example, pain scores 
based on three items correlated 0.93 with the scores based on all 16 items. However, as the 
evaluations were based on the data used to calibrate the IRT model, the efficiency and 
precision may have been overestimated. We intend to conduct additional studies to examine 
these issues in independent data.  
 
The results of the known-groups comparisons based on observed data indicated that, if four or 
more items are asked, sample sizes may be reduced by 20-25% without loss of power as 
compared to the QLQ-C30. The simulations on the other hand indicated that this reduction 
would be at most 10-15%. Hence, both analyses indicate increased power using the new 
 19 
measure, but it is inconclusive what the actual gain may be and this will probably vary across 
studies. Additional, detailed evaluations of the power of the CAT measure in independent data 
are needed and are planned.  
 
The EORTC CAT pain measure includes the two QLQ-C30 pain items, and all new items 
have been constructed and selected to measure the same pain aspects as the C30 items and to 
have the same item format. The purpose of this was to obtain a homogenous and user-friendly 
measure measuring the same concept as the QLQ-C30 pain scale. Based on the strong 
associations between the original and new items it seems reasonable to assume that the new 
measure is also valid. However, it would still be interesting and relevant to compare the 
EORTC CAT pain instrument with external, validated pain measures. This will elucidate the 
validity and importantly, will also allow the construction of linking (Chen et al., 2009; 
Dorans, 2007) (also called cross-walking (Noonan et al., 2012)) between the EORTC pain 
measure and other established pain measures. 
 
Although the development of the EORTC CAT has not yet been completed, the current 
version may be used for “experimental” purposes. By “experimental” is meant that until the 
final, validated version of the EORTC CAT is released, it should be used in parallel with the 
EORTC QLQ-C30. The EORTC CAT item banks may also be used to construct so called 
(paper) short forms. For example, if a trial is comparing a new analgesic to the standard 
treatment, then to increase the study power (without increasing sample size) it may be 
advantageous to supplement the QLQ-C30 with a pain short form of e.g. five additional pain 
items, targeted to the study population. As the items are selected from the calibrated item 
bank, scores based on such short forms are directly comparable to scores based on the CAT 
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measure. For more information on this preliminary use of the EORTC CAT and short forms 
please visit http://groups.eortc.be/qol/eortc-cat. 
 
In conclusion, we have developed an item bank of 16 items for CAT measurement of pain. 
This CAT measure will be backward compatible with the QLQ-C30 and hence with the many 
studies that have used this questionnaire. The item bank showed good psychometric 
properties and high measurement precision for patients with some degree of pain. It is for 
these patients that more detailed information would be particularly useful. Evaluations of 
power were somewhat ambiguous, but indicated that sample sizes may be reduced up to 25% 
without loss of power, compared to the QLQ-C30. However, these measurement properties 
should be validated with new data before drawing any final conclusions. Even though the item 
bank is targeted cancer patients, the items are formulated in general, non-cancer specific terms 
and hence may be applied in other patient populations (and the general population) as well.  
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Figure legends 
Fig. 1. Test information function for the 16 items in the final model and for the two EORTC 
QLQ-C30 pain items, respectively. 
 
Footnote to Fig. 1: The pain scores obtained if answering “not at all”, “a little”, “quite a bit”, or “very much”, 
respectively to all 16 items are indicated at the horizontal axis. 
 
 
Fig. 2. Median and percentiles for differences between pain scores based on fixed length 
CATs and scores based on all items. 
 
 
Fig. 3. The average relative validity and relative required sample size using CAT 
measurement compared to using the QLQ-C30 sum scale based on observed and simulated 
data, respectively. 
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Table 1. Sociodemographic and clinical characteristics of the field study sample (N=1,103). 
  N/mean 
Age (mean years)  60 (range 19-90) 
Gender Male 484 (44%) 
 Female 619 (56%) 
Country Denmark 435 (39%) 
 Italy 81 (7%) 
 Sweden 220 (20%) 
 Taiwan 103 (9%) 
 UK 264 (24%) 
Education  0-10 years 335 (30%) 
 11-13 years 275 (25%) 
 14-16 years 236 (21%) 
 >16 years 232 (21%) 
Work Working 391 (30%) 
 Retired 516 (47%) 
 Other 172 (16%) 
Cohabitation Living with a partner 817 (74%) 
 Living alone 266 (24%) 
Cancer stage I-II 536 (49%) 
 III-IV 518 (47%) 
Cancer site Breast 199 (18%) 
 Gastrointestinal 131 (12%) 
 Gynaecological 179 (16%) 
 Head and neck 165 (15%) 
 Lung 33 (3%) 
 Other 191 (17%) 
Current treatment Chemotherapy 249 (23%) 
 Other treatment 271 (24%) 
 No current treatment 577 (52%) 
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Table 2. Parameter estimates (slope and location) and fit statistics for the 16 items in the final IRT model.  
Item (Heading for all items: during the past week) Slope Location 
Item fit,  
p-value 
Bias Infit Outfit 
1. Have you had any trouble falling asleep because of pain?
a 
1.59 1.06 0.109 0.01 0.98 0.93 
2. Has pain made it difficult for you to do the jobs that you 
usually do around the house?
a 2.25 0.62 0.122 -0.04 0.92 0.89 
3. Have you had extreme pain?
b 
2.45 0.87 0.425 -0.04 0.96 1.03 
4. Has pain made it difficult for you to stand for more than a 
few minutes?
a
 
1.49 1.35 0.558 -0.00 1.03 0.88 
6. Have you had pain you could not ignore?
b
 1.70 0.56 0.546 -0.03 0.86 0.85 
7. Have you had to stay in bed during the day because of 
pain?
a
 
1.87 1.52 0.323 -0.02 1.07 0.84 
8. Has pain limited your ability to concentrate on work or 
other daily activities?
a
  
2.53 0.81 0.205 -0.01 1.00 0.87 
10. Have you had any trouble sleeping because of pain?
a
 2.10 0.88 0.190 0.02 0.94 0.83 
11. Has pain interfered with your leisure activities (e.g. sports 
and hobbies)?
a
 
1.99 0.39 0.043 -0.07 0.91 0.88 
13. Has pain interfered with your social activities?
a
 2.72 0.69 0.307 0.00 0.94 0.81 
14. Have you had severe pain?
b
 2.43 0.78 0.603 -0.02 0.89 0.94 
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15. Have you woken up earlier than you wanted to because of 
pain?
a
 
2.06 0.84 0.431 0.03 0.93 0.82 
16. Has pain made it difficult for you to sit for more than 1 
hour?
a
 
1.56 1.29 0.586 -0.01 0.96 0.88 
17. Did pain interfere with your daily activities? (QLQ-C30 
item 19)
a
 
2.64 0.59 0.124 0.01 0.76 0.71 
18. Have you had any trouble taking a walk because of pain?
a
 1.70 0.64 0.166 0.01 1.04 0.95 
21. Have you had pain? (QLQ-C30 item 9)
b
 2.26 -0.28 0.400 -0.04 0.80 0.84 
a
: Item measures primarily pain interference. 
b
: Item measures primarily pain intensity. 
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